GAMMA Investing’s Eledon Pharmaceuticals ELDN Stock Holding History

GAMMA Investing’s Portfolio ELDN Stock Details ELDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.32K	Buy	1,709 +521	+44%	+$1.75K	﹤0.01%	3707
2026 Q2	$4.68K	Hold	1,188	–	–	﹤0.01%	3495
2026 Q1	$3.66K	Buy	+1,188	New	+$2.8K	﹤0.01%	3486

Other funds holding ELDN

EFG

Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return

GWM

GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Planning Strategies Lancaster, Pennsylvania $169M AUM

BAM

Byrne Asset Management Kingston, New Jersey $179M AUM 29.67% 1-Year Est. Return

GAMMA Investing's ELDN Position: Q3 2026 in Review

GAMMA Investing increased its Eledon Pharmaceuticals (ELDN) stake by 44% in Q3 2026, buying an estimated $1.75K and bringing the position to 1,709 shares worth $4.32K. The position accounts for ﹤0.01% of the portfolio, ranked #3707.

GAMMA Investing first reported a position in ELDN in Q1 2026 and has held it in 3 quarters since. The position peaked at $4.68K in Q2 2026. 7 funds tracked by Wall St. Rank hold ELDN as of Q3 2026.

GAMMA Investing held 1,709 shares of Eledon Pharmaceuticals worth $4.32K as of Q3 2026.
GAMMA Investing bought 521 Eledon Pharmaceuticals shares in Q3 2026, an estimated $1.75K.
Eledon Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3707 holding.
GAMMA Investing first reported a position in Eledon Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
GAMMA Investing's Eledon Pharmaceuticals position peaked at $4.68K in Q2 2026.
7 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.